BioNTech boosts 2021 vaccine supply forecast to 2 billion doses

BioNTech boosts 2021 vaccine supply forecast to 2 billion doses
  • Clock-gray 18:27
  • calendar-gray 11 January 2021

German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses, APA reports citing Economic Times.

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," said the company, referring to the additional dose that could be extracted from each vial of the vaccine.

apa-logo-mini

Other news